Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 28487 | 205 | 31.1 | 32% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
| 3041 | 2 | PSK//OK 432//IMEXON | 2463 |
| 28487 | 1 | ADJUVANT SPECIFIC IMMUNOTHERAPY//CHEMOTACTIC INHIBITORS//CHIMERIC ANTIBODY 311 | 205 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ADJUVANT SPECIFIC IMMUNOTHERAPY | authKW | 148953 | 0% | 100% | 1 |
| 2 | CHEMOTACTIC INHIBITORS | authKW | 148953 | 0% | 100% | 1 |
| 3 | CHIMERIC ANTIBODY 311 | authKW | 148953 | 0% | 100% | 1 |
| 4 | CLONAL ORIGIN OF EVOLUTION | authKW | 148953 | 0% | 100% | 1 |
| 5 | COLON CANCER ANTIGENS | authKW | 148953 | 0% | 100% | 1 |
| 6 | COLON MONOCLONAL ANTIBODIES | authKW | 148953 | 0% | 100% | 1 |
| 7 | COLON TUMOR ANTIGEN | authKW | 148953 | 0% | 100% | 1 |
| 8 | COST OF CONDUCTING HEALTH RESEARCH STUDIES | authKW | 148953 | 0% | 100% | 1 |
| 9 | EMPYEMA POSTOPERATIVE | authKW | 148953 | 0% | 100% | 1 |
| 10 | HOMOTRANSPLANTABLE TUMOR | authKW | 148953 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 1167 | 40% | 0% | 81 |
| 2 | Respiratory System | 613 | 15% | 0% | 30 |
| 3 | Immunology | 405 | 22% | 0% | 46 |
| 4 | Medicine, General & Internal | 65 | 10% | 0% | 20 |
| 5 | Pathology | 45 | 5% | 0% | 10 |
| 6 | Surgery | 31 | 9% | 0% | 18 |
| 7 | Critical Care Medicine | 23 | 2% | 0% | 5 |
| 8 | Cardiac & Cardiovascular System | 22 | 5% | 0% | 11 |
| 9 | Clinical Neurology | 15 | 5% | 0% | 11 |
| 10 | Medicine, Research & Experimental | 7 | 3% | 0% | 7 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ONCOL HONORARY | 148953 | 0% | 100% | 1 |
| 2 | SERV THORAC SURG VIA ROMA 65 | 148953 | 0% | 100% | 1 |
| 3 | HJ TAGNON | 74476 | 0% | 50% | 1 |
| 4 | PULM ALLERGY CRIT CAREMED | 74476 | 0% | 50% | 1 |
| 5 | SECT INTERVENT PULMONOL THORAC ONCOL | 54162 | 1% | 18% | 2 |
| 6 | INVEST CLIN ONCOL EXPT | 21277 | 0% | 14% | 1 |
| 7 | PNEUMOL TB | 18617 | 0% | 13% | 1 |
| 8 | GENET PLANT BREEDING BIOTECHNOL | 16549 | 0% | 11% | 1 |
| 9 | SMOKING CESSAT PROGRAM | 11456 | 0% | 8% | 1 |
| 10 | UC IRVINE MED | 6204 | 0% | 4% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 9910 | 8% | 0% | 17 |
| 2 | JOURNAL OF THE MAINE MEDICAL ASSOCIATION | 5956 | 0% | 4% | 1 |
| 3 | JOURNAL OF CANCER | 3178 | 2% | 1% | 4 |
| 4 | CONTROLLED CLINICAL TRIALS | 2449 | 2% | 0% | 4 |
| 5 | INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 1261 | 1% | 0% | 2 |
| 6 | CRITICAL REVIEWS IN IMMUNOLOGY | 963 | 1% | 0% | 2 |
| 7 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS | 906 | 0% | 1% | 1 |
| 8 | JOURNAL OF TUMOR MARKER ONCOLOGY | 890 | 0% | 1% | 1 |
| 9 | CANCER DETECTION AND PREVENTION | 842 | 1% | 0% | 3 |
| 10 | SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 793 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | STANLEY, K , (1986) IMMUNOSTIMULATION WITH INTRAPLEURAL BCG AS ADJUVANT THERAPY IN RESECTED NON-SMALL CELL LUNG-CANCER.CANCER. VOL. 58. ISSUE 11. P. 2411-2416 | 11 | 92% | 4 |
| 2 | ARLEN, M , TSANG, A , MARCHILDON, G , WANG, T , SCHERRER, J , (1997) IMMUNODIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF COLON CANCER USING PROTEIN DERIVED MONOCLONAL ANTIBODY 31.1.JOURNAL OF TUMOR MARKER ONCOLOGY. VOL. 12. ISSUE 1. P. 5-11 | 5 | 100% | 0 |
| 3 | DIGIORGIO, A , SAMMARTINO, P , ARNONE, P , CANAVESE, A , ALMANSOUR, M , (1996) PROGNOSTIC SIGNIFICANCE OF POSTOPERATIVE EMPYEMA IN LUNG CANCER.INTERNATIONAL SURGERY. VOL. 81. ISSUE 4. P. 407-411 | 5 | 100% | 0 |
| 4 | LAW, MR , LAM, WK , HODSON, ME , (1988) POSTOPERATIVE INTRAPLEURAL BCG IN LUNG-CANCER.EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY. VOL. 24. ISSUE 9. P. 1527-1528 | 8 | 89% | 2 |
| 5 | BAKKER, W , NIJHUISHEDDES, JMA , VANDERVELDE, EA , (1986) POSTOPERATIVE INTRAPLEURAL BCG IN LUNG-CANCER - A 5-YEAR FOLLOW-UP REPORT.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 22. ISSUE 2. P. 155-159 | 12 | 57% | 9 |
| 6 | ARLEN, M , TSANG, A , WANG, T , (1998) IMMUNOTHERAPY OF COLON CANCER USING CHIMERIC MAB 31.1.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 18. ISSUE 1-2. P. 133 -138 | 5 | 71% | 2 |
| 7 | ARLEN, M , SARIC, O , WANG, XP , DUBEYKOVSKIY, A , ARLEN, P , (2013) NANOCYTOLOGY VS. IMMUNOHISTOCHEMISTRY OF INTESTINAL COLONOCYTES TO ASSESS THE RISK OF COLON CANCER BASED ON FIELD CANCERIZATION - A PRELIMINARY REPORT.JOURNAL OF CANCER. VOL. 4. ISSUE 2. P. 165-169 | 3 | 75% | 2 |
| 8 | ARLEN, M , CRAWFORD, J , COPPA, G , SARIC, O , BANDOVIC, J , DOUBAKOVSKI, A , SULLIVAN, J , CONTE, C , KADISON, A , PROCACCINO, J , ET AL (2014) THE CAUSE AND PREVENTION OF ANASTOMOTIC RECURRENCE FOLLOWING COLECTOMY: AN IMMUNOHISTOCHEMICAL APPROACH FOR DETECTING TRANSFORMING COLONOCYTES.JOURNAL OF CANCER. VOL. 5. ISSUE 9. P. 784 -789 | 4 | 44% | 1 |
| 9 | EVANS, DA , ROBERTS, HL , HEWITT, S , WALSH, D , DONOHOE, WTA , LAMBOURNE, A , (1987) A TRIAL OF ADJUVANT IMMUNOTHERAPY FOR BRONCHIAL-CARCINOMA WITH IRRADIATED AUTOCHTHONOUS TUMOR-CELLS.INTERNATIONAL JOURNAL OF IMMUNOTHERAPY. VOL. 3. ISSUE 4. P. 293-300 | 7 | 64% | 0 |
| 10 | HOLLINSHEAD, A , TAKITA, H , STEWART, T , RAMAN, S , (1988) SPECIFIC ACTIVE LUNG-CANCER IMMUNOTHERAPY - IMMUNE CORRELATES OF CLINICAL-RESPONSES AND AN UPDATE OF IMMUNOTHERAPY TRIALS EVALUATIONS.CANCER. VOL. 62. ISSUE 8. P. 1662-1671 | 4 | 100% | 10 |
Classes with closest relation at Level 1 |